throbber
2006
`
`USP 29
`THE UNITED STATES PHARMACOPEIA
`
`NF 24
`THE NATIONAL FORMULARY
`
`By authority of The United States Pharmacopeial
`Convention, meeting at Washington, D. C, March 9—13,
`2005. Prepared by the Council ofExperts and published
`by the Board of Trustees
`
`Ofiicial from January I, 2006
`
`The designation on the cover of this publication, “USP NF
`2006,” is for ease of identification only. The publication
`contains two separate compendia: The United States
`Pharmacopeia, Twenty-Ninth Revision, and the National
`Formulary, Twenty—Fourth Edition.
`
`THE UNITED STATES PHARMACOPEIAL CONVENTION
`
`12601 Twinbrook Parkway, Rockville, MD 20852
`
`Argentum EX1044
`Argentum EX1044
`Page 1
`
`Page 1
`
`

`

`NOTICE AND WARNING
`
`Concerning US. Patent or Trademark Rights
`
`The inclusion in The United States Pharmacopeia or in the National Formulary ofa monograph on any drug
`in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of,
`or authority to exercise, any right 'or privilege protected by such patent or trademark. All Such rights and
`privileges are vested in the patent or trademark owner, and no other person may exercise the same without
`express permission, authority, or license secured from such patent or trademark owner.
`
`Concerning Use of USP or NF Text
`
`Attention is called to the fact that USP and NF text is fully copyrighted. Authors and others wishing to use
`portions of the text should request permission to do so from the Secretary of the USPC Board of Trustees.
`
`Copyright © 2005 The United States Pharrnacopeial Convention
`12601 Twinbrook Parkway, Rockville, MD 20852
`All rights reserved.
`.
`ISSN 0195-7996
`-
`"
`‘
`ISBN 1-889788—39-2
`Printed in Canada by Webcom Limited, Toronto, Ohtario
`
`-
`
`Page 2
`
`Page 2
`
`

`

`2552
`
`(197) Spectrophotometric Identification Tests / Chemical Tests
`
`respective Pharmacopeial dosage forms. Two procedures are
`provided, one based on paper chromatography (Method 1) and the
`other on thin-layer chromatography (Method II). Method 1 is to be
`used unless otherwise directed in the individual monograph.
`Standard Solution—Unless otherwise directed in the individual
`monograph, dissolve the USP Reference Standard for the drug
`substanCe being identified in the same solvent and at the same
`concentration as for the Test Solution.
`
`Test Solution—Prepare as directed1n the individual monograph.
`
`METHOD I
`
`pH 3.5 Buffer—Dissolve 13.4 g of anhydrous citric acid and
`16.3 g of dibasic sodium phosphate in 1000 mL of water, and mix.
`Developing Solvent—On the day of use, mix 10 volumes of
`chloroform, 20 volumes of nitromethane, and 3 volumes of pyridine.
`. Mixed Test Solution—Mix equal volumes of the Standard
`Solution and the Test Solution.
`
`Chromatographic Sheet—Draw a spotting line 2.5 cm from one
`edge of a 20—cm X ‘20-cm sheet of filter paper (Whatman No. l, or
`equivalent). Impregnate the sheet with pH 3.5 Buffer by passing it
`through a trough filled with pH 3.5 Bufler, and remove the excess
`solvent by firmly pressing the sheet between nonfluorescent blotting
`papers.
`Procedure—«To a- suitable chromatographic chamber, prepared for
`ascending chromatography (see Chromatography (621)) add Devel-
`oping Solvent to a depth of 0.6 cm. Apply at 1.5-cm intervals 2 uL
`each of the Standard Solution, the Test Solution, and the Mixed Test
`Solution to the spotting line of the Chromatographic Sheet. Allow the
`sheet to dry partially, and while still damp place .it
`in the
`chromatographic chamber with the bottom edge touching the
`Developing Solvent. When the solvent front has risen about 10 cm,
`remove the sheet from the chamber, and expose the sheet to. ammonia
`vapor. Examine the chromatogram under long—wavelength UV light.
`Record thepositions of the major yellow fluorescent spots: the RF
`value, of the principal spot obtained from the Test Solution and from
`the Mixed Test Solution corresponds to that obtained from. the
`Standard Solution.
`
`METHOD II
`
`Resolution Solution—Unless otherwise directed1n the individual
`monograph, prepare a solutionIn methanol containing 0.5 mg each of
`USP Chlortetracycline Hydrochloride. RS, USP Doxycycline Hyclate
`RS, USP Oxytetracycline RS, and USP Tetracycline Hydrochloride
`IRS per mL.
`. Developing Solvent—Prepare a mixture of 05M oxalic acid,
`previously adjusted with ammonium hydroxide to a pH of 2.0
`acetonitrile, and methanol (80: 20: 20).
`Chromatographic Plate-Use a suitable thin~layer chromato-
`graphic plate (see Thin—layer Chromatography under Chromatogra-
`phy (621))- coated with a 0. 25--mm layer of octylsilanized
`chromatographic silica gel mixture Activate the plate by heating it
`at 1300 for 20 minutes, allow to cool, and use while still warm.
`Procedure—Separately apply 1 11L each of the Standard Solution,
`the Test Solution, and the Resolution Solution to the Chromato-
`graphic Plate. Allow the spots to dry, and develop the chromatogram
`in the Developing Solvent until the solvent front has moved about
`three-fourths of the length of the plate. Remove the plate from the
`developing chamber, mark the solvent front, and allow to air-dry.
`Expose the plate to ammonia vapors for 5 minutes, and promptly
`locate the spots on the plate by viewing under long—wavelength UV
`light: the chromatogram of the Resolution Solution shows clearly
`separated spots, and the principal spot obtained from the Test Solution
`corresponds in RF value, intensity, and appearance to that obtained
`from the Standard Solution
`
`1'
`
`
`(197) SPECTROPHOTOMETRIQ}:
`.
`IDENTIFICATION TESTS '1
`
`Spectrophotometric tests contribute meaningfully toward;
`
`identification of many compendial chemical substances. The
`procedures that follow are applicable to substances that abso '6
`
`and/(gr UV radiation (see Spectrophotometry and Light--Sc II
`851 ).
`.-
`The IR absorption spectrum of a substance, compared wi
`I
`
`obtained concomitantly for the corresponding USP Ref
`
`Standard, provides perhaps the most conclusive evidence
`identity ofthe substance that can be realized from any single test.
`
`
`UV absorption spectrum, 0n the other hand, does not exhib'
`
`degree of specificity. Conformance with both IR absorption an
`
`absorption test specifications, as called forIn a large proportr 4'
`compendial monographs leaves little doubt, if any, regardin ‘
`
`identity of the specirnen under examination.
`
`
`. INFRARED ABSORPTION
`Six methods are indicated for the preparation of previously :I
`test specimens 'and Reference Standards for analysis. The ref '7:
`
`the substance 14
`I.
`(197K)
`in a monograph ‘ signifies that
`examination is mixed intimately. with potassium bromide' 1
`
`reference (197M)In a monograph signifies that the substance 11
`examination is finely ground and dispersed in mineral oil; 1
`
`reference (197F) in a monograph signifies that the substance u
`examination is suspended neat between suitable (for'example, s 1
`
`chloride or potassium bromide), platesxThe reference (1978) si
`that a solution of designated concentration .is-prepared in the:
`
`specifiedIn the individual monograph, and the solution is ex:
`in 0.1—mm cells unless a different cell path length15 specified
`
`I
`individual monograph. The reference (197A)
`signifies
`substance under examination is intimately1n contact with an '
`
`reflection element for attenuated total reflectance (ATR) anal
`
`reference (197E)srgnifies that the substance under examin
`pressed as a thin sample against a suitable plate for. IR mic
`analysis The ATR (197A) and the (197E) techniques can b
`alternative methods for (197K), (197M), (197F),'qand (1978)
`
`
`testingrs perfdrmed qualitatively and the Reference Standard s‘I"_-I'I:
`are similarly obtained
`Record the spectra of the test specimen and the corresponding
`Reference Standard over the range from about 2. 6 pm to 15 um
`cm‘l
`to 650 cm“) unless otherwise specified in the in
`
`monograph. The IR absorption spectrum of the preparation 0
`specimen, previously dried under conditions specified to ,‘
`
`corresponding Reference Standard unless otherwise spec‘- '
`‘
`unless the Reference Standard is to be used without drying,
`
`maxima only atthe same wavelengths as that ofa similar pr
`,
`of the corresponding USP Reference Standard
`
`Differences that may be observed in the spectra- so ob
`sometimes are attributed to the presence of polymorphs, wh ~
`
`not always acceptable (see Procedure under Spectrophotome ;,
`
`Light-Scattering (851)) Unless otherWise directedin the indi
`monograph, therefore, continue as fellows. If a difference ap Ff
`
`the IR spectra of the analyte and the standard, dissolve equal 1 1
`ofthe test specimen and the Reference StandardIn equal voIlu
`
`suitable solvent, evaporate the solution to
`containers under identical conditions, and repeat the test,’
`
`I
`residues.
`
`ULTRAVIOLET ABSORPTION
`
`
`The reference (197U)In a monOgraph signifies that a test s6
`
`and a Standard solution are examined spectrbphotometrically;
`cm cells, over the spectral range from 200 to 400 nm unless o .
`specifiedIn the individual monograph
`
`Dissolve a portion of the substance under examinatio
`designated Medium to obtain a test solution having the cone
`
`specifiedIn the monograph for Solution. Similarly prepare a
`solution containing the corresponding USP Reference Stan
`
`‘Page 3
`
`Page 3
`
`

`

`P29
`
`Chemical Tests / (201) Thin-Layer Chromatographic Identification Test
`
`2553
`
`Record and compare the spectra concomitantly obtained for the test
`lugtion and the Standard solution. Calculate absorptiViti'es and/or
`orbance ratios where these criteria are included111 an individual
`nograph Unless otherwise specified, absorbances indiCated for
`e calculationsare ‘thoSe measured at the maximum absorbanceat
`iwut the wavelength specifiedin the individual monograph. Where
`abSOrbance1s to be measured at about the specified wavelength
`«er than that of maximum absorbance, the abbreviations (min) and
`*1) are used to indicate a minimum and shoulder, respectively,1n an
`orption spectrum. The requirements are met if the UV absorption
`ctra of the test solution and the Standard solution exhibit maxima
`I minirna at
`the same Wavelengths and absorptivities and/0r
`sorbance ratios are within specified limits
`
`(201) THIN-LAYER
`CHROMATOGRAPHIC
`IDENTIFICATION TEST
`
`GENERAL PROCEDURE
`
`1.
`
`;
`'4
`
`1
`
`-;3,The following procedure18 applicable as an aid1n verifying the
`‘ntities of many compendial drug substances as such andIn their
`5Lpective dosage forms.
`Prepare a test solution as directed1n the individual monograph. On
`ine parallel to and about 2 cm from the edge of a suitable thin-layer
`., cmatographic plate, coated with a 0. 25--mm layer of chromato—
`mphic silica gel mixture (see Chromatography (621)) apply 10 11L
`1 this solution and 1011L of a Standard solution prepared from the
`gs? Reference Standard for the drug substance being identified, in
`same solvent and at the same concentration as the testsolutiOn,
`igess otherwise directed in the individual monograph. A110w the
`fits to dry, and develop the chromatogram in a solvent system
`insisting of a mixture of chloroform, methanol, and water
`1» ':0 15. 1), unless otherwise directed1n tlie individual monograph,
`' ii the solvent front has moved about three—fourths of the length of
`plate. Remove the plate from the developing chamber, mark the
`Vent front, and allow the solvent to evaporate. Unless otherwise
`ted1n the individual monograph, locate the spots on the plate by
`ination under short-wavelength UV light. The RF VaII‘Ie of the
`n'cipal spot obtained from the test solution corresponds to that
`'itained from the Standard solution.
`
`ROCEDURE FOR BACITRACIN, NEOMYCIN,
`;
`AND POLYMYXIN B
`3
`
`The following thin-layer chromatographic procedure1s applicable
`, an aid in verifying the identities of bacitracin, neomycin, and
`lymyxin B active ingredients and in dosage forms when present
`,glyv and in two- and three-component mixtures. The reference
`01BNP) in a monograph signifies that this procedureIS intended
`,Prepare a Test Solution as follows, unless otherwise directed1n the
`'1.1 Vidual monograph.
`Test Solution—
`FOR DRUG SUBSTANCES—Dissolve a portion of Bacitracin,
`,:_ itracin Zinc, Neomycin Sulfate, or Polymyxin B Sulfate in
`N hydrochloric acid to obtain a solution contaimng about 500
`isP Bacitracin Units per mL, 3.5 mg of neomycin (base) per mL, or
`1,1,000 USP Polymyxin B Units per mL.
`FOR SOLUTIONS—Where the Solution contains neomycin and
`‘ ymyxin B, dilute a portion of it with 0.1N hydrochloric acid to
`'tain a solution containing the equivalent of about 3.5 mg of
`‘ umycin (base) per mL. Where the Solution contains polymyxin B
`
`but not neomycin, dilute a portion of it with 0.1 N hydrochloric acid
`to obtain a solution containing about 10,000 USP Polymyxin B Units
`per mL.
`FOR CREAMS, LOTIONS, AND orNTMENTs—Where the Cream, Letion,
`or Ointment contains Bacitracin or Bacitracin Zinc, transfer a portion
`of it equivalent to about 500 USP Bacitracin Units, to a 15-mL
`centrifuge tube. Where the Cream, Lotion, or Ointment contains
`neomycin, but not Bacitracin or Bacitracin Zinc, transfer a portion of
`it equivalent to about 3.5 mg of neomycin (base)per mL to a 15 —mL
`centrifuge tube. Add 4 mL Of chloroform to the centrifuge tube, and
`shake well to disperse the Cream, Lotion, or Ointment. Add 1 mL of
`0.1 N hydrochloric acid, vortex for 4 minutes, centrifuge, and use the
`clear supernatant.
`,NOTE—LThe Modfied Test Solution as described belowin the Modified
`Procedure may be usedin lieu of the Test Solution.
`Standard Bacitracin Solution—~Dissolve a portion of .USP
`Bacitracin Zinc RS in 0.1 N hydrochloric acid to obtain a solution
`containing 500 USP Bacitracin Units permL.
`Standard Neomycin Solution—Dissolve a portion of USP
`Neomycin Sulfate RS in 0.1 N hydrochloric acid to obtain a solution
`containing the equivalent of 3.5 mg of neomycin (base) per .mL.
`'Standard Polymyxin B-Solution—Dissolve a portion of USP
`Polymyxin B Sulfate RS in 0.1N hydrochloric acid to obtain a
`solution containing 10,000 USP Polymyxin B Units per mL. Where
`the article under test. also contains Bacitracin or Bacitracin Zinc,
`dissolve a portion of‘ USP Polymyxin B Sulfate RS in 0.1 N
`hydrochloric acid to obtain a solution containing 500] USP
`Polymyxin B Units per mL, J being the ratio of the labeled amount
`of USP Polymyxin BUnits to the labeled amount of USP Bacitracin
`Units in each g of Cream, Lotion, or Ointment.
`Developing Solvent Solution—Prepare a mixture of methanol,
`isopropyl alcohol, methylene Chloride, ammonium hydroxide, and
`water(4: 2. 2:2: 1..5)
`ProcedurFApp1y_10 11L of the Test Solution and each of the
`relevant Standard Solutions to a suitable thin——layer chromatographic
`plate (see Chromatography (621)) coated witha 0.25-mm layer of
`chromatographic silica gel. Place the plate in a presaturated
`chromatographic chamber, and develop the chromatogram with the
`Developing Solvent System until the solvent front has moved about
`three-fourths of the length of the plate. Remove the plate from the
`chamber, and dry at 105° for 10 minutes. Spray the plate with a 0.2%
`Solution of ninhydrin in butyl alcohol, and heat at 105° fer 5 minutes.
`The RF value of each principal spot in the chromatogram of theTest
`Solution corresponds to that of the principal spot in the chromatogram
`obtained from each relevant Standard Solution as appropriate for the
`labeled active ingredient or ingredients specified on the label. If the
`chromatogram .of the Test Solution yields excessive streaking,
`proceed as directed for Modified Procedure.
`Modified Procedure—Transfer the Test Solution to a 15-mL
`centrifuge tube, add 10 mL of saturated aqueous picric acid solution
`(1.2%, w/v), vortex for 1 minute, centrifuge for 10 minutes, and
`discard the supernatant. Wash the residue with 1 -m_L portions of
`water until no yellow color1s observed1n the washing. Discard the
`washings, and dry the residue under a stream of nitrogen at 50°.
`Dissolve the residue in 1 mL of aCetone, add 1 mL of a freshly
`prepared solution of sulfuric acid in acetone (1 in 100), shake,
`centrifuge for 5 minutes, and discard the supernatant. Rinse the
`residue gwith 1 mL of acetone, centrifuge briefly, and discard the
`washing. Repeat the washing until no yellow color1s observed. Dry
`the residue under a stream of nitrogen at 50°. Dissolve the residueIn
`0.5 mL of 0.1 N hydrochloric acid (Modified Test Solution). Repeat
`the Procedure using this Modified Test Solution instead of the Test
`Solution. The RF value of each principal spot in the chromatogram of
`the Modified Test Solution corresponds to that of the principal spot in
`the chromatogram obtained from each relevant Standard Solution as
`appropriate for the active ingredient or ingredients specified on the
`label.
`
`
`
`Page 4
`
`Page 4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket